Emmaus Life Sciences, Inc.
EMMA
$0.07
$0.019.23%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -6.02M | -8.50M | -7.49M | -7.29M | -3.39M |
| Total Depreciation and Amortization | 59.00K | 49.00K | 39.00K | 29.00K | 19.00K |
| Total Amortization of Deferred Charges | 611.00K | 625.00K | 560.00K | 445.00K | 372.00K |
| Total Other Non-Cash Items | 2.61M | 1.10M | 974.00K | -383.00K | -3.12M |
| Change in Net Operating Assets | 6.71M | 6.09M | 5.91M | 5.32M | 3.98M |
| Cash from Operations | 3.97M | -634.00K | -11.00K | -1.88M | -2.14M |
| Capital Expenditure | -2.00K | -1.00K | -1.00K | -7.00K | -6.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 4.00K | 4.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.58M | 2.17M | 2.17M | 2.17M | 2.17M |
| Cash from Investing | 1.58M | 2.17M | 2.17M | 2.17M | 2.17M |
| Total Debt Issued | 5.78M | 7.81M | 7.91M | 5.47M | 4.95M |
| Total Debt Repaid | -9.38M | -9.60M | -9.33M | -6.73M | -5.64M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -3.60M | -1.78M | -1.43M | -1.26M | -694.00K |
| Foreign Exchange rate Adjustments | -21.00K | -16.00K | 3.00K | 4.00K | 22.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.92M | -261.00K | 738.00K | -962.00K | -640.00K |